Cardiopulmonary Bypass (CPB) Pumps and Blood Activation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by University Hospital, Angers.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT00187967
First received: September 9, 2005
Last updated: September 24, 2007
Last verified: September 2005
  Purpose

Blood activation induced by cardiopulmonary bypass may compromise the postoperative outcome. The goal of this study is to compare blood activation induced by cardiopulmonary bypass performed with centrifugal pump or roller pump in patients undergoing coronary artery surgery.


Condition Intervention
Cardiopulmonary Bypass
Coronary Artery Disease
Device: pumps used for cardiopulmonary bypass

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Blood Activation During Cardiopulmonary Bypass Using Roller or Centrifugal Pumps

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

Study Start Date: January 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Men undergoing coronary artery bypass grafting using cardiopulmonary bypass
  • Aspirin therapy

Exclusion Criteria:

  • Redo surgery
  • Acute coronary syndrome requiring urgent surgery
  • Oral anticoagulant therapy
  • Organ dysfunction or chronic inflammatory disease
  • Surgery other than coronary artery bypass grafting
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00187967

Contacts
Contact: Anthony Bailleul 33-(0)2-41-35-58-91

Locations
France
University Hospital of Angers Recruiting
Angers, France, 49933
Contact: Christophe Baufreton, MD, PhD    33-(0)2-41-35-45-73    ChBaufreton@chu-angers.fr   
Contact: Anthony Bailleul    33-(0)2-41-35-58-91      
Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Christophe Baufreton, MD, PhD University Hospital of Angers, France
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00187967     History of Changes
Other Study ID Numbers: PHRC 03-03
Study First Received: September 9, 2005
Last Updated: September 24, 2007
Health Authority: France: Ministry of Health

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on July 22, 2014